Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
NOVEL AGENTS IN THE TREATMENT OF LUNG CANCER First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in EGFR Mutation Positive Non-small Cell Lung Cancer Patients Lecia V. Sequist, MD, MPH 2– 4,12 smoking, female sex, and East Asian ethnicity. This sce- Small molecule tyrosine kinase inhibitors of the epidermal growth nario, an identifiable molecular marker that predicts a marked factor receptor (EGFR) are important agents in the treatment of differential response to a given therapy, is an ideal one for non-small cell lung cancer (NSCLC) and have enhanced activity in testing the promise of genotype-directed therapy. The geno- the subpopulation of patients with NSCLC who harbor somatic type-directed strategy aims to abandon the traditional clinical activating mutations of the EGFR gene. This review summarizes the oncology approach of treating all patients with the same data describing the use of EGFR tyrosine kinase inhibitors in a histologic diagnosis under the same treatment algorithm in genotype-directed population of NSCLC patients with EGFR muta- favor of a more specific molecular analysis at the time of tions and discusses areas that require further study. diagnosis that has the power to elucidate optimal therapies for Key Words: Non-small cell lung cancer, Epidermal growth factor
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Jun 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.